A randomised controlled trial to investigate the effect of regular moderate intensity exercise on plasma fibrinogen in people with type two diabetes: a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN98564438

Enrollment

Registered

2005-09-30

Start date

2003-06-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type two diabetes Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

Randomised controlled trial

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 80 patients with type two diabetes

Exclusion criteria

Exclusion criteria: 1. Smokers 2. Taking drugs affecting clotting 3. Inability to exercise

Design outcomes

Primary

Measure	Time frame
1. Plasma fibrinogen 2. Plasminogen activator inhibitor-1 (PAI-1)	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026